2018-2019学期文献学习记录
发表时间： 2019-09-20 作者:
|
日期 |
文献名 |
杂志 |
汇报人 |
|
2018.11.08 |
Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes |
Journal of Bone and Mineral Research |
林茜茜 |
|
2018.11.15 |
STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex |
Cell Death & Differentiation |
付方胜 |
|
2018.11.29 |
Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone. |
Cancer Res |
袁桂鑫 |
|
2018.12.6 |
Cartilaginous extracellular matrix derived from decellularized chondrocyte sheets for the reconstruction of osteochondral defects in rabbits |
Acta Biomaterialia |
车志刚 |
|
2018.12.13 |
TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid. |
丁佳昕 |
|
|
2018.12.20 |
Cross Talk Between Autophagy and Apoptosis Contributes to ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death |
Adv. Healthcare Mater |
李真 |
|
2018.12.27 |
Understanding the Bone in Cancer Metastasis |
Journal of Bone and Mineral Research |
李凯 |
|
2019.01.04 |
Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss |
肖宇 |
|
|
2019.01.10 |
Epigenetic inhibition of Wnt pathway suppresses osteogenic differentiation of BMSCs during osteoporosis. |
Cell Death & Disease |
湛云飞 |
|
2019.02.28 |
Elimination of senescent osteoclast progenitors has no effect on the age‐associated loss of bone mass in mice |
Aging Cell |
田昆 |
|
2019.03.07 |
Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species. |
Theranostics |
蒋捷 |
|
2019.03.14 |
Bevacizumab, an anti-vascular endothelial growth factor antibody,inhibits osteoarthritis. |
李毅成 |
|
|
2019.03.21 |
Tyrosine kinase Fyn promotes osteoarthritis by activating the β-catenin pathway. |
Ann. Rheum. Dis. |
李毅成 |
|
2019.03.28 |
Ninjurin1 positively regulates osteoclast development by enhancing the survival of prefusion osteoclasts. |
Experimental & Molecular Medicine |
江长幸 |
|
2019.04.11 |
A theranostic nanoplatform: magneto-gold@fluorescence polymer nanoparticles for tumor targeting T1&T2-MRI/CT/NIR fluorescence imaging and induction of genuine autophagy mediated chemotherapy |
丁佳昕 |
|
|
2019.04.18 |
Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation. |
The Journal of Clinical Investigation |
吴佐星 |
|
2019.04.25 |
Anacardic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo. |
The FASEB Journal |
邵思远 |
|
2019.05.09 |
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. |
袁三瞏 |
|
|
2019.05.16 |
Diabetes impairs wound healing by Dnmt1-dependent dysregulation of hematopoietic stem cells differentiation towards macrophages. |
连浩宇 |
|
|
2019.05.23 |
Stem Cells in the Treatment of Disease. |
Th e new england journal o f medicine |
马步国 |
|
2019.05.30 |
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation |
Cell Death＆Differentiation |
李晨 |
|
2019.06.06 |
Activation of the Nrf2/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury |
Oncotarget |
丁佳昕 |
|
2019.06.13 |
CHIP regulates bone mass by targeting multiple TRAF family members in bone marrow stromal cells |
Bone Research |
陈润峰 |
|
2019.06.20 |
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss |
Nature Medicine |
吴佐星/邵思远 |
|
2019.06.27 |
BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model |
Cell Death & Disease |
杨雪 |
|
2019.07.04 |
Sirtuin 6 in preosteoclasts suppresses age- and estrogen deficiency-related bone loss by stabilizing estrogen receptor α |
Cell Death & Differentiation |
李雪东 |
打印
关闭
